ALLO Financials
Allogene Therapeutics Inc - Financial statements & key metrics
Stock Price
$2.15
Market Cap
$510.14M
EPS
$-0.87
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$22,000
Gross Profit
-
Operating Income
-
Net Income
$-257.59M
EPS (Diluted)
$-1.32
Balance Sheet Highlights
Total Assets
$548.71M
Total Liabilities
$126.53M
Shareholders Equity
-
Cash & Equivalents
$75.22M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-200.30M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-0.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ALLO revenue?
ALLO's most recent quarterly revenue was $22,000. Annual revenue can be calculated by summing the four most recent quarters.
Is ALLO profitable?
ALLO reported a loss of $257.59M in the most recent quarter.
What is ALLO market cap?
ALLO has a market capitalization of $510.14M, making it a small-cap stock.
Does ALLO have debt?
View ALLO's balance sheet for debt information.
What is ALLO cash flow?
Cash flow data is available in the full financial statements.